Products and technical work
Observed October 20, 2026: Its Transpara portfolio describes breast-cancer detection, density assessment and comparison with prior examinations for 2D and 3D mammography workflows. Research question (analysis): How are reader workflow, false alerts and cross-vendor imaging performance evaluated for each deployment?
Company-published product scope, not independent validation of clinical efficacy, regulatory authorization, security, customer outcomes or employer quality. The research question is analysis, not an advertised job requirement.
Read the source